Genomma Lab (Mexico) Analysis

Genomma Stock Analysis Notes

About 29.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.51. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Genomma Lab Internacional last dividend was issued on the 9th of November 2022. The entity had 2:1 split on the 3rd of August 2010. Genomma Lab Internacional, S.A.B. de C.V. together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico, the United States, and Latin America. Genomma Lab Internacional, S.A.B. de C.V. was founded in 1996 and is based in Mexico City, Mexico. GENOMMA LAB operates under Drug ManufacturersSpecialty Generic classification in Mexico and is traded on Mexico Stock Exchange. It employs 1451 people. To find out more about Genomma Lab Internacional contact Maximo Juda at 52 55 5081 0000 or learn more at https://www.genommalab.com.

Genomma Lab Internacional Investment Alerts

Genomma Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 18.09 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genomma Lab's market, we take the total number of its shares issued and multiply it by Genomma Lab's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Genomma Profitablity

The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.2 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.2.

Technical Drivers

As of the 25th of April, Genomma Lab retains the Risk Adjusted Performance of 0.0503, downside deviation of 2.12, and Market Risk Adjusted Performance of 0.5121. Concerning fundamental indicators, the technical analysis model lets you check existing technical drivers of Genomma Lab Internacional, as well as the relationship between them. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Genomma Lab Internacional, which can be compared to its competitors. Please check out Genomma Lab Internacional jensen alpha, maximum drawdown, and the relationship between the information ratio and treynor ratio to decide if Genomma Lab is priced fairly, providing market reflects its last-minute price of 14.59 per share.

Genomma Lab Internacional Price Movement Analysis

Genomma Lab Predictive Daily Indicators

Genomma Lab Forecast Models

Genomma Lab's time-series forecasting models are one of many Genomma Lab's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Genomma Lab's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Genomma Lab prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Genomma shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Genomma Lab. By using and applying Genomma Stock analysis, traders can create a robust methodology for identifying Genomma entry and exit points for their positions.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Genomma Lab Internacional. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

When running Genomma Lab's price analysis, check to measure Genomma Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genomma Lab is operating at the current time. Most of Genomma Lab's value examination focuses on studying past and present price action to predict the probability of Genomma Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genomma Lab's price. Additionally, you may evaluate how the addition of Genomma Lab to your portfolios can decrease your overall portfolio volatility.